Dr. Elise Erickson Receives $2.9M RO1 Award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development

The University of Arizona College of Nursing is proud to acknowledge the extraordinary achievement of Assistant Professor Elise Erickson, PhD, CNM, FACNM, and her colleagues, for receiving an R01 award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

This 5-year, $2.9M grant will allow Dr. Erickson and her interdisciplinary team to investigate new markers for improving the detection and prevention of maternal morbidity. This is an exciting and important project that exemplifies the College’s commitment to advancing scientific knowledge and dedication to life-changing research endeavors.

"This funding support will not only help us advance our knowledge of why some individuals respond better or worse the most commonly used medication for labor and postpartum hemorrhage management, oxytocin, but it allows us to also train more scientists and students in the field of maternal health," Dr. Erickson said. "Addressing the poor maternal morbidity statistics in our nation is going to take a lot of strategies, and we’re thrilled to be able to have the support to grow our team and hopefully stimulate innovation through personalized maternity care."

Principal Investigator: Dr. Elise Erickson, PhD, MSN, BSN, Assistant Professor, College of Nursing

Co-Investigators: Dr. Jason Karnes, PharmD, PhD, BCPS, FAHA, Associate Professor,  College of Pharmacy: Pharmacy Practice and Science

Dr. Christopher Banek, PhD, Assistant Professor, College of Medicine: Physiological Sciences/Neuroscience

Dr. Jessica Connelly, PhD, Professor, University of Virginia, Department of Psychology: Systems and Behavioral Neuroscience

Primary Clinical Collaborator: Dr. Rachel Darché, MD, Clinical Assistant Professor and OB/GYN Residency Program Director, College of Medicine, BUMC-T

Award Number: 1R01HD111125

Title: Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity

Total Costs: $2,929,208

Project Period: 08/01/2023 – 05/31/2028

Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R01HD111125. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.